Iodide

Iodide

SCHEMBL633577

CCCc1nccn1C.I

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
LPO P22079 1/20 0.41
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
TSHR P16473 1/20 0.38
KCNH2 Q12809 1/20 0.36
TLR8 Q9NR97 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
CNR2 P34972 1/20 0.35
OPRK1 P41145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48932 0.98
Bromide SCHEMBL27242084 0.96 FDPS (0.43) FDPSKMT2AMEN1LPOALDH1A1
Hydrochloric Acid SCHEMBL26676426 0.96 FDPS (0.43) FDPSKMT2AMEN1LPOALDH1A1
Ammonia Solution, Strong SCHEMBL27683928 0.96 FDPS (0.43) FDPSKMT2AMEN1LPOALDH1A1
SCHEMBL30101478 0.96 FDPS (0.43) FDPSKMT2AMEN1LPOALDH1A1
Hydrochloric Acid SCHEMBL30754387 0.96 FDPS (0.43) FDPSKMT2AMEN1LPOALDH1A1
Bromide SCHEMBL28245379 0.94 FDPS (0.42) FDPSKMT2AMEN1LPOALDH1A1
SCHEMBL28288135 0.90 FDPS (0.40) FDPSKMT2AMEN1LPOALDH1A1
Iodide SCHEMBL526909 0.88 KMT2A (0.44) FDPSKMT2AMEN1LPOALDH1A1
Formic Acid SCHEMBL2524899 0.87 KMT2A (0.45) FDPSKMT2AMEN1LPOALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140034869-A1 Gel Electrolytes For Dye Sensitized Solar Cells MERCK PATENT GMBH (DE) 2014-02-06 US claimed
US-8581096-B2 Gel electrolytes for dye sensitized solar cells MERCK PATENT GMBH (DE) 2013-11-12 US claimed
US-8513519-B2 Use of exfoliated clay nanoplatelets and method for encapsulating cations NATIONAL TAIWAN UNIVERSITY (TW) 2013-08-20 US claimed
US-20110031429-A1 Use of exfoliated clay nanoplatelets and method for encapsulating cations NATIONAL TAIWAN UNIVERSITY (TW) 2011-02-10 US claimed
US-20090272934-A1 GEL ELECTROLYTES FOR DYE SENSITIZED SOLAR CELLS MERCK KGAA (DE) 2009-11-05 US claimed
EP-1963546-A2 ELECTROCHEMICAL SYSTEM COMPRISING PHOTOACTIVE ELEMENTS Hydrogen Solar Ltd. (GB) 2008-09-03 EP claimed
WO-2007066087-A2 ELECTROCHEMICAL SYSTEM COMPRISING PHOTOACTIVE ELEMENTS HYDROGEN SOLAR LTD (GB) 2007-06-14 WO claimed
JP-2005516365-A 2005-06-02 JP claimed
US-6900382-B2 Gel electrolytes for dye sensitized solar cells KONARKA TECHNOLOGIES, INC. (US) 2005-05-31 US claimed
US-20050039790-A1 Gel electrolytes for dye sensitized solar cells KONARKA TECHNOLOGIES, INC. (US) 2005-02-24 US claimed
EP-1470563-A2 PHOTOVOLTAIC CELL COMPONENTS AND MATERIALS Konarka Technologies, Inc. (US) 2004-10-27 EP claimed
US-20040025933-A1 Gel electrolytes for dye sensitized solar cells KONARKA TECHNOLOGIES, INC. (US) 2004-02-12 US claimed
WO-2003065394-A2 PHOTOVOLTAIC CELL COMPONENTS AND MATERIALS KONARKA TECHNOLOGIES, INC. (US) 2003-08-07 WO claimed
US-12559586-B2 Compositions containing uretdione groups crosslinking at low temperatures COVESTRO DEUTSCHLAND AG (DE) 2026-02-24 US disclosed
WO-2024204638-A1 PHOTOELECTRIC CONVERSION ELEMENT AND PRODUCTION METHOD FOR SAME シャープ株式会社 2024-10-03 WO disclosed
US-20230192941-A1 COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES COVESTRO DEUTSCHLAND AG (DE) 2023-06-22 US disclosed
WO-2003065393-A2 DISPLAYS WITH INTEGRATED PHOTOVOLTAIC CELLS KONARKA TECHNOLOGIES, INC. (US) 2003-08-07 WO disclosed
WO-2003065471-A2 PHOTOVOLTAIC FIBERS KONARKA TECHNOLOGIES, INC. (US) 2003-08-07 WO disclosed
WO-2003065394-A2 PHOTOVOLTAIC CELL COMPONENTS AND MATERIALS KONARKA TECHNOLOGIES, INC. (US) 2003-08-07 WO disclosed
WO-2003065472-A2 STRUCTURES AND MATERIALS FOR DYE SENSITIZED SOLAR CELLS KONARKA TECHNOLOGIES, INC. (US) 2003-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559586-B2 Compositions containing uretdione groups crosslinking at low temperatures URB2, UQCRB, UQCRC2 FDPS 3376/4885KMT2A 4285/4885MEN1 2202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.